Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial.
暂无分享，去创建一个
C. Tournigand | W. Scheithauer | D. Vernerey | F. Bonnetain | A. Larsen | A. de Gramont | F. Viret | J. Latreille | T. André | C. Louvet | N. Tubiana-Mathieu | G. Lledo | B. Chibaudel | P. Mésange | J. Dauba | N. Aucoin | O. Dupuis | M. Mabro | B. Samson | Y. Rinaldi | J. Ramée